US FDA Approves Vepdegestrant, World's First PROTAC-Based Therapy, for Advanced Breast Cancer
The U.S. Food and Drug Administration (FDA) has approved vepdegestrant, the world's first therapy built on PROTAC (Proteolysis-Targeting Chimera) technology.Vepdegestrant is an oral drug developed by Arvinas and Pfizer.I...